PharmaVoice

JULY 7, 2025

Estimates vary for how many patients with either obesity or diabetes stop using the drugs, but one 2024 study pegged the discontinuation between 50% and 75% within a year. Launches DSai™ — AI-Powered Digital Sign-In to Modernize HCP Event Compliance in L… From Groupize.ai © 2025 TechTarget, Inc. or its subsidiaries.

Compounding

Pharma Marketing Network

NOVEMBER 7, 2024

Event Reminders : Automate reminders for webinars or conferences. Here’s a quick look at a successful email campaign in pharma: Objective : Increase awareness about a new diabetes drug. Using Automation for Efficiency Automation can make your life easier and your campaigns more effective.

HIPAA

The Pharmacist

JUNE 25, 2025

A consultant pharmacist has issued warnings about the risks to patients when obtaining weight loss medications online, at a virtual GP Pharmacy event, yesterday.

Diabetes

PharmaVoice

JULY 8, 2025

And if you can do that, cancer becomes a chronic, manageable disease, like diabetes, cardiac disease or HIV. Launches DSai™ — AI-Powered Digital Sign-In to Modernize HCP Event Compliance in L… From Groupize.ai I think we have to control cancer before we cure it.” © 2025 TechTarget, Inc. or its subsidiaries. All rights reserved.

Immunity

pharmaphorum

JULY 24, 2025

Skip to main content Thursday 24 July 2025 BlueSky linkedin youtube rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & (..)

Diabetes

Beckers Hospital Review

JULY 3, 2025

events per month to an average of 1.54 events per month, and the average patient length of stay decreased from 3.44 The technology also helps virtual care center teams remotely monitor patients at home, reducing at-home diabetes patients’ hemoglobin A1c levels by about 25%. Sioux Falls, S.D.-based minutes to 35.4

Documentation

Pharmacy Times

JULY 16, 2025

Difficile COPD COVID-19 Cardiovascular Health Cervical Cancer Cholangiocarcinoma Cholesterol Chronic Kidney Disease Chronic Lymphocytic Leukemia Classical Hematology Colorectal Cancer Continuous Glucose Monitoring Cough and Cold Depression Dermatology Diabetes Digestive Health Dry Eye Disease Epilepsy Eye Care Flu Future of Pharmacy Gastrointestinal (..)

Vaccines

Pharma Marketing Network

NOVEMBER 24, 2024

Optimize your website to be mobile-friendly and create value-driven content around trending topics like “best treatment options for diabetes” to drive traffic. For instance, a diabetes educator discussing the benefits of Ozempic can create authenticity and trust in your brand. Tailor messages for each platform.

Pharmaceutical Companies

ALiEM - Pharm Pearls

OCTOBER 30, 2024

That discussion can be deferred until the patient is stable, the risk of such an event is mitigated, and other medications can be given for their withdrawal symptoms and pain. Multi-Substance Use Substances such as cocaine, amphetamines, and benzodiazepines often are used concurrently, which can confound the management plan.

HIV Treatment and Prevention Agents

Commonwealth Pharmacists Association

JUNE 30, 2025

The pharmacist in Malaysia, inspiring global peers with their fresh approach to diabetes care. The early-career practitioner in Ghana, using data and design tools to reshape antimicrobial use in their community. The National Pharmacy Association leader in Tanzania, growing local membership and influencing policy on a national level.

Health and Personal Care Stores

Express Pharma

JULY 13, 2025

Eli Lilly and Co’s orforglipron is emerging as a promising oral glucagon-like peptide (GLP)-1 therapy, with upcoming clinical milestones in obesity and diabetes set to shape its market trajectory. The report covers 18 significant catalyst events that are expected to occur in Q3 2025. billion for orforglipron in 2031.

Diabetes

pharmaphorum

JUNE 20, 2025

Skip to main content Friday 20 June 2025 BlueSky linkedin youtube rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & (..)

Diabetes

Express Pharma

APRIL 8, 2025

Novo Nordisk has released full results from the SOUL cardiovascular outcomes trial, a phase 3b study evaluating the impact of oral semaglutide on adults with type 2 diabetes who also have cardiovascular disease (CVD) and/or chronic kidney disease (CKD). Notably, participants from the Asian region showed a 27 per cent reduction in MACE risk.

Diabetes

Pharma Marketing Network

JUNE 21, 2025

Agile content frameworks now allow for templated messaging and pre-approved creative assets, enabling brands to quickly respond to current events or public health crises. However, social content doesn’t have to be slow. When dealing with branded drug mentions, the balance becomes even more critical.

Prescription Filling

Express Pharma

MARCH 2, 2025

As in earlier years, week-long events have been planned at various locations across the country from March 1 to 7, 2025. At the initiative of Prime Minister Narendra Modi, March 7 is celebrated every year as Jan Aushadhi Diwas to enhance awareness about the scheme and promote generic medicines.

Generic Medicine

Pharma Marketing Network

JULY 2, 2025

For instance, campaigns focusing on chronic illness management, such as diabetes or rare diseases, foster genuine engagement. Social media marketing strategies in this sector depend on a deep understanding of FDA guidance, adverse event reporting, and promotional labeling limits. Platforms must be leveraged carefully.

Labelling

Express Pharma

JULY 16, 2025

Most treatment-emergent adverse events (TEAEs) were gastrointestinal-related and mild to moderate in severity. Participants did not have diabetes. About HRS9531 (KAI-9531) HRS9531 is a dual GLP-1/GIP receptor agonist in development as an injectable peptide for type 2 diabetes, obesity and related metabolic conditions.

Diabetes

Pharmacy Times

JUNE 24, 2025

Difficile COPD COVID-19 Cardiovascular Health Cervical Cancer Cholangiocarcinoma Cholesterol Chronic Kidney Disease Chronic Lymphocytic Leukemia Classical Hematology Colorectal Cancer Continuous Glucose Monitoring Cough and Cold Depression Dermatology Diabetes Digestive Health Dry Eye Disease Epilepsy Eye Care Flu Future of Pharmacy Gastrointestinal (..)

Pharmacy Technician

Express Pharma

NOVEMBER 21, 2024

This innovation is designed to treat Community-Acquired Bacterial Pneumonia (CABP), a severe illness caused by drug-resistant bacteria, which disproportionately affects vulnerable populations, including children and the elderly as well as immune-compromised hosts like patients with diabetes, cancers etc.

Diabetes

National Association of Boards of Pharmacy

JULY 23, 2025

For example, a DUR could reference a patient’s demographics, medical history, and current conditions such as diabetes, asthma, or high blood pressure. Any adverse events experienced by the patients are fully addressed. Medication lists are complete and updated. Baseline and ongoing patient labs are reviewed.

Adverse Reactions

Pharmacy Times

JULY 16, 2025

Subscribe Now!

HIV Treatment and Prevention Agents

Express Pharma

JUNE 24, 2025

Wegovy is a once-weekly glucagon-like peptide-1 receptor agonist (GLP-1 RA) and is the first medication in India indicated for both long-term chronic weight management and the reduction of major adverse cardiovascular events in people living with obesity or overweight. According to clinical data, semaglutide 2.4

Diabetes

Pharmacy Times

JUNE 20, 2025

Difficile COPD COVID-19 Cardiovascular Health Cervical Cancer Cholangiocarcinoma Cholesterol Chronic Kidney Disease Chronic Lymphocytic Leukemia Classical Hematology Colorectal Cancer Continuous Glucose Monitoring Cough and Cold Depression Dermatology Diabetes Digestive Health Dry Eye Disease Epilepsy Eye Care Flu Future of Pharmacy Gastrointestinal (..)

Vaccines

Pharmacy Times

JUNE 20, 2025

Difficile COPD COVID-19 Cardiovascular Health Cervical Cancer Cholangiocarcinoma Cholesterol Chronic Kidney Disease Chronic Lymphocytic Leukemia Classical Hematology Colorectal Cancer Continuous Glucose Monitoring Cough and Cold Depression Dermatology Diabetes Digestive Health Dry Eye Disease Epilepsy Eye Care Flu Future of Pharmacy Gastrointestinal (..)

Pharmacy Technician

Pharmacy Times

JULY 22, 2025

Maccia, PharmD, BCCCP Kinsey M. Johannemann, PharmD, BCPS Eden E. Brewington, PharmD, BCCCP Daniel C.

Pharmacy Technician

Pharmacy Times

JULY 22, 2025

Furthermore, delays in medication access can exacerbate chronic conditions, such as diabetes, hypertension, and asthma, leading to increased hospitalization rates. Patients may be unable to obtain critical medications, resulting in poor adherence and negative outcomes.

Pharmacy Technician

Pharmacy Times

JUNE 27, 2025

Treatment-related adverse events (AEs) included nausea (77.8% Baseline disease characteristics included stage IV disease in 89% (TN) and 95% (R/R) of patients, high-risk Mantle Cell Lymphoma International Prognostic Index scores in 11% and 15%, bulky disease over 5 cm in 17% and 30%, and blastoid morphology in 6% and 15%, respectively.

Pharmacy Technician

Pharmacy Times

JULY 21, 2025

Difficile COPD COVID-19 Cardiovascular Health Cervical Cancer Cholangiocarcinoma Cholesterol Chronic Kidney Disease Chronic Lymphocytic Leukemia Classical Hematology Colorectal Cancer Continuous Glucose Monitoring Cough and Cold Depression Dermatology Diabetes Digestive Health Dry Eye Disease Epilepsy Eye Care Flu Future of Pharmacy Gastrointestinal (..)

Pharmacy Technician

Putting Patients First Blog

JUNE 24, 2025

This is especially important for those living with a chronic disease or condition, as heatwaves can exacerbate conditions like respiratory and cardiovascular diseases, diabetes, dementia, renal disease, and musculoskeletal disease, according to the World Health Organization. Some tips from to the U.S.

Communication

Pharmacy Times

JUNE 24, 2025

Difficile COPD COVID-19 Cardiovascular Health Cervical Cancer Cholangiocarcinoma Cholesterol Chronic Kidney Disease Chronic Lymphocytic Leukemia Classical Hematology Colorectal Cancer Continuous Glucose Monitoring Cough and Cold Depression Dermatology Diabetes Digestive Health Dry Eye Disease Epilepsy Eye Care Flu Future of Pharmacy Gastrointestinal (..)

Pharmacy Technician

Pharmacy Times

JULY 21, 2025

CGMs offer continuous glucose data, allowing for timely interventions, but face challenges like cost, sensor malfunctions, and technical issues.

Pharmacy Technician

Pharmacy Times

JULY 26, 2025

Although some of these medications have additional FDA-approved uses (ie, rivaroxaban to reduce the risk of thrombotic vascular events in patients with peripheral artery disease), all 4 DOACs are approved for the treatment and prevention of venous thromboembolism and stroke prevention in nonvalvular atrial fibrillation (AFib).

Pharmacy Technician

Pharmacy Times

JUNE 18, 2025

2 More recent changes in many states include the ability to prescribe oral contraceptives and plan outreach events to monitor blood pressure or cholesterol; the latter, when coupled with referral to appropriate medical services, is a valuable intervention. 2 The pharmacy profession needs to improve in 2 areas.

Pharmacy Technician

Pharmacy Times

JUNE 9, 2025

Difficile COPD COVID-19 Cardiovascular Health Cervical Cancer Cholangiocarcinoma Cholesterol Chronic Kidney Disease Chronic Lymphocytic Leukemia Classical Hematology Colorectal Cancer Continuous Glucose Monitoring Cough and Cold Depression Dermatology Diabetes Digestive Health Dry Eye Disease Epilepsy Eye Care Flu Future of Pharmacy Gastrointestinal (..)

Pharmacy Technician

Pharmacy Times

JULY 12, 2025

Difficile COPD COVID-19 Cardiovascular Health Cervical Cancer Cholangiocarcinoma Cholesterol Chronic Kidney Disease Chronic Lymphocytic Leukemia Classical Hematology Colorectal Cancer Continuous Glucose Monitoring Cough and Cold Depression Dermatology Diabetes Digestive Health Dry Eye Disease Epilepsy Eye Care Flu Future of Pharmacy Gastrointestinal (..)

Pharmacy Technician

Pharmacy Times

JUNE 12, 2025

These events foster innovation, collaboration, and professional growth within the oncology pharmacy community. Participants can present their work, exchange ideas, and connect with leaders in the field during these networking opportunities.

Pharmacy Technician

Pharmacy Times

JUNE 19, 2025

Nacher : I think, as I said, rusfertide being a first-in-class hepcidin mimetic is huge—especially for patients with [PV]—to hopefully reduce the phlebotomy burden and prevent some of the sequelae of the disease, including cardiovascular and thrombotic events.

Pharmacy Technician